3,185
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Analytical evaluation and clinical application of insulin and C-peptide by a whole blood, lateral flow, point of care (POC) assay system

, , , , , & show all
Pages 347-353 | Received 17 Dec 2018, Accepted 30 May 2019, Published online: 18 Jun 2019

References

  • International Diabetes Foundation. IDF Diabetes Atlas-7th Edition. DiabetesAtlas [Internet]. Belgium. IDF: [cited 2018 Apr 20]. Available from: http://www.diabetesatlas.org/
  • Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98.
  • Nanditha A, Ma RC, Ramachandran A, et al. Diabetes in Asia and the Pacific: implications for the global epidemic. Diabetes Care. 2016;39:472–485.
  • Zimmet PZ. Diabetes and its drivers: the largest epidemic in human history? Clin Diabetes Endocrinol. 2017;3:1–8.
  • Skyler JS, Bakris GL, Bonifacio E, et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes. 2017;66:241–255.
  • Raven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75:473–486.
  • Leibiger I, Leibiger B, Berggren P. Insulin feedback action on pancreatic beta-cell function. FEBS Lett. 2002;532:1–6.
  • Matthaei S, Stumvoll M, Kellerer M, et al. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev. 2000;21:585–518.
  • Singh B, Saxena A. Surrogate markers of insulin resistance: a review. World J Diabetes. 2010;1:36–47.
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62–S69.
  • DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–194.
  • Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens. 1998;16:895–896.
  • Clinical and Laboratory Standard Institute. Evaluation of precision performance of quantitative measurement methods; approved guideline, CLSI document EP05-A3. 3rd ed. Wayne (PA): Clinical and Laboratory Standard Institute; 2014.
  • Ricos C, Alvarez V, Cava F, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest. 1999;59:491–500.
  • Clinical and Laboratory Standard Institute. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline, CLSI document EP06-A. Wayne (PA): Clinical and Laboratory Standard Institute; 2003.
  • Clinical and Laboratory Standard Institute. Evaluation of detection capability for clinical laboratory measurement procedures; approved guideline, CLSI document EP17-A2. Wayne (PA): Clinical and Laboratory Standard Institute; 2012.
  • American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Caret. 2018;41:S13–S27.
  • Clinical and Laboratory Standard Institute. Measurement procedure comparison and bias estimation using patient samples; approved guideline, CLSI document EP09-A3. Wayne (PA): Clinical and Laboratory Standard Institute; 2013.
  • HOMA calculator [Internet]. United Kingdom. [cited 2018 Dec 01]. Available from: http://www.dtu.ox.ac.uk/homacalculator/
  • Guerrero-Romero F, Simental ML, Gonzalez-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347–3351.
  • Ohkura T, Shiochi H, Fujioka Y, et al. 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report. Cardiovasc Diabetol. 2013;12:21–29.
  • Sluiter W, Erkelens D, Terpstra P, et al. A mathematical approach II: approximation of the peripheral insulin resistance after oral glucose loading. BMC Public Health. 1976;25:245–249.
  • Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–419.
  • Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–2410.
  • Duncan MH, Singh BM, Wise PH, et al. A simple measure of insulin resistance. Lancet. 1995;346:120–121.
  • Hanson R, Pratley R, Bogardus C, et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol. 2000;151:190–198.
  • Raynaud E, Perez-Martin A, Brun JF, et al. Relationships between fibrinogen and insulin resistance. Atherosclerosis. 2000;150:365–370.
  • Manley SE, Stratton IM, Clark PM, et al. Comparison of 11 human insulin assays: implications for clinical investigation and research. Clin Chem. 2007;53:922–932.
  • Tohidi M, Arbab P, Ghasemi A. Assay-dependent variability of serum insulin concentrations: a comparison of eight assays. Scand J Clin Lab Invest. 2017;77:122–129.
  • Little RR, Rohlfing CL, Tennill AL, et al. Standardization of C-peptide measurements. Clin Chem. 2008;54:1023–1026.
  • Little RR, Wielgosz RI, Josephs R, et al. Implementing a reference measurement system for C-peptide: successes and lessons learned. Clin Chem. 2017;63:1447–1456.
  • Little RR, Kinumi T, Connolly S, et al. Implementing a reference measurement system for C-peptide: an Addendum. [letter]. Clin Chem. 2017;63:1904–1905.
  • Ascaso J, Pardo S, Real J, et al. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26:3320–3325.